1.Risk factors analysis on central venous catheter-related thrombosis in critically ill children
Hanfang DENG ; Zhimin YANG ; Wenlan ZHANG ; Li YUAN ; Long XIANG ; Wenyi LUO
Chinese Pediatric Emergency Medicine 2025;32(6):431-436
Objective:To investigate the current status and risk factors of central venous catheter-related thrombus(CRT)in critically ill children,and to provide evidence for proposing preventive measures.Methods:This study was a single-center cross-sectional survey.The hospitalized children with central venous catheters implanted in the intensive care unit of Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine from January to March 2024 were included.Based on the ultrasound diagnosis indicating CRT or the presence of visually detectable thrombi after central venous catheter removal,the children included in the study were categorized into the CRT group and the non-CRT group.The data of demographic,clinical data,laboratory tests,medication treatment,and catheter related information of the affected children were collected.Univariate and multivariate analyses were performed to identify risk factors associated with CRT.Results:A total of 328 children were included,of which 158 cases(48.2%)were female,with the median age of 35.00(9.00,88.75)months.There were 51 cases(15.6%)in CRT group and 277 cases(84.4%)in non-CRT group.After adjusted by pediatric critical illness score,multivariate binary Logistic analysis revealed that the use of normal saline for catheter flushing and sealing (adjust OR=26.52,95% CI 8.32-84.60, P<0.001),longer duration of vasoactive drug use (adjust OR=5.06,95% CI 1.93-13.26, P=0.001),higher Caprini scale score (adjust OR=3.09,95% CI 1.38-6.91, P=0.006),presence of high-risk comorbidities or complications (adjust OR=2.87,95% CI 1.11-7.45, P=0.030),longer immobilization time (adjust OR=1.13,95% CI 1.07-1.19, P<0.001),and lower international normalized ratio after catheter placement (adjust OR=0.10,95% CI 0.02-0.53, P=0.007) were independent risk factors affecting the occurrence of CRT. Conclusion:The incidence of CRT is relatively high among critically ill children,and medical staff can develop targeted intervention measures by taking relevant risk factors into consideration.
2.Risk factors analysis on central venous catheter-related thrombosis in critically ill children
Hanfang DENG ; Zhimin YANG ; Wenlan ZHANG ; Li YUAN ; Long XIANG ; Wenyi LUO
Chinese Pediatric Emergency Medicine 2025;32(6):431-436
Objective:To investigate the current status and risk factors of central venous catheter-related thrombus(CRT)in critically ill children,and to provide evidence for proposing preventive measures.Methods:This study was a single-center cross-sectional survey.The hospitalized children with central venous catheters implanted in the intensive care unit of Shanghai Children's Medical Center,Shanghai Jiao Tong University School of Medicine from January to March 2024 were included.Based on the ultrasound diagnosis indicating CRT or the presence of visually detectable thrombi after central venous catheter removal,the children included in the study were categorized into the CRT group and the non-CRT group.The data of demographic,clinical data,laboratory tests,medication treatment,and catheter related information of the affected children were collected.Univariate and multivariate analyses were performed to identify risk factors associated with CRT.Results:A total of 328 children were included,of which 158 cases(48.2%)were female,with the median age of 35.00(9.00,88.75)months.There were 51 cases(15.6%)in CRT group and 277 cases(84.4%)in non-CRT group.After adjusted by pediatric critical illness score,multivariate binary Logistic analysis revealed that the use of normal saline for catheter flushing and sealing (adjust OR=26.52,95% CI 8.32-84.60, P<0.001),longer duration of vasoactive drug use (adjust OR=5.06,95% CI 1.93-13.26, P=0.001),higher Caprini scale score (adjust OR=3.09,95% CI 1.38-6.91, P=0.006),presence of high-risk comorbidities or complications (adjust OR=2.87,95% CI 1.11-7.45, P=0.030),longer immobilization time (adjust OR=1.13,95% CI 1.07-1.19, P<0.001),and lower international normalized ratio after catheter placement (adjust OR=0.10,95% CI 0.02-0.53, P=0.007) were independent risk factors affecting the occurrence of CRT. Conclusion:The incidence of CRT is relatively high among critically ill children,and medical staff can develop targeted intervention measures by taking relevant risk factors into consideration.
3.Study on active components of Fufang Huangbai Ye for diabetic foot treatment by UPLC-LTQ-Orbitrap-MS and network pharmacology.
Xin LI ; Huan-Huan WANG ; Jing XU ; Li-Ying TANG ; Deng-Feng LI ; Yi ZHANG ; Qiang JIA ; Hong-Jun YANG ; Hong-Wei WU ; Jing-Jing ZHANG
China Journal of Chinese Materia Medica 2019;44(10):2110-2117
Chemical constituents of the Fufang Huangbai Ye( FFHB) were analyzed and identified by UPLC-ESI-LTQ-OrbitrapMS. The analysis was performed on an Waters HSS T3 reverse phase column( 2. 1 mm×100 mm,1. 8 μm). The mobile phase consisting of 0. 1% aqueous formic acid( A) and acetonitrile( B) was used with gradient elution,and the flow rate was 0. 3 mL·min~(-1).Based on the information of the accurate mass,the multistage fragment ions,the mass spectrometric data of the standard substance and the relative reference literature,the structure of the chemical constituents in FFHB were identified. Based on the identified compounds,network pharmacology study,including target prediction,functional enrichment,and molecular docking was applied to screen out the main active substances for treatment of diabetes foot and explore the potential mechanism. The results showed that a total of 138 compounds were identified,including 28 alkaloids,16 flavonoids,11 phenylethanoid glycosides,9 cycloolefins,11 cyclohexylethanol derivatives,28 phenolic acids and derivatives,3 lignans,4 terpenes,28 volatile oils and the others. Further,36 active substances for diabetes foot were screened out,and the functional enrichment showed the potential mechanism of FFHB were mainly seven functional items including inflammatory response,growth factor activity. This study combining the UPLC-LTQ-Orbitrap-MS technology and the network pharmacology provide a useful reference and basis for active compounds,quality control markers and the pharmacological mechanism of FFHB for diabetic foot treatment.
Chromatography, High Pressure Liquid
;
Diabetic Foot
;
drug therapy
;
Drugs, Chinese Herbal
;
pharmacology
;
Humans
;
Mass Spectrometry
;
Molecular Docking Simulation
;
Phytochemicals
;
isolation & purification
;
pharmacology

Result Analysis
Print
Save
E-mail